Tag: Research
-
Precision Medicine for “All of Us”
Northwestern will play a key role in “All of Us,” a groundbreaking national research effort to gather data from one million or more people in order to advance precision medicine.
-
New Insights Into Protein’s Role in Inflammatory Response
A protein called POP2 inhibits a key inflammatory pathway, calming the body’s inflammatory response before it can become destructive, Northwestern Medicine scientists have found.
-
Reversing Fetal Alcohol Damage After Birth
Two commonly used drugs erased the learning and memory deficits caused by fetal alcohol exposure when the drugs were given after birth, according to a new study.
-
How Babies’ Environments Lead to Poor Health Later
Northwestern scientists have found that nutritional, microbial and psychosocial exposures early in infant development predict DNA methylation later in life.
-
New Technology to Manipulate Cells Could One Day Help Treat Parkinson’s, Arthritis, Other Diseases
A synthetic material developed at Northwestern Medicine could direct a patient’s existing cells to transform into stem cells, creating a new treatment path for stem cell therapy.
-
Novel Screening Method Reveals Glioblastoma Drug Target
Scientists used a new approach to identify a promising therapeutic target for glioblastoma, which was previously overlooked in traditional approaches.
-
Investigating Relevance of Internal Medicine Recertification Exam
Almost 70 percent of questions on the American Board of Internal Medicine’s Maintenance of Certification exam concurred with the frequency of conditions seen in general internal medicine practice, according to a JAMA study.
-
Investigating the Survival Benefit of Aggressive Procedure for Melanoma
Patients with melanoma that has spread to the sentinel nodes did not see any survival benefit after a surgical procedure called immediate completion lymph node dissection, according to a study in the New England Journal of Medicine.
-
Investigating the Financial Burden of Cancer Drugs on Medicare Patients
The rising cost of targeted oral anticancer medications may put a substantial financial burden on individual patients enrolled in Medicare’s prescription drug benefit program, Part D, according to a new study.
-
Nanomedicine Opens Door to Precision Medicine for Brain Tumors
Early phase Northwestern Medicine research has demonstrated a potential new therapeutic strategy for treating glioblastoma.
